BRAF基因突变与皮肤恶性黑素瘤 |
| |
引用本文: | 郑博文,何黎,张林,邹勇莉. BRAF基因突变与皮肤恶性黑素瘤[J]. 国际皮肤性病学杂志, 2007, 35(1): 251-253. DOI: 10.3760/cma.j.issn.1673-4173.2009.04.022 |
| |
作者姓名: | 郑博文 何黎 张林 邹勇莉 |
| |
作者单位: | 昆明医学院第一附属医院皮肤科,650032;昆明医学院第一附属医院病理科,650032; |
| |
摘 要: | ![]() BRAF基因,位于染色体7q34编码一个67 000~99 000的丝,苏氨酸蛋白激酶,其产物在丝裂原活化蛋白激酶信号途径中起重要调控作用.国内外的研究者先后发现并揭示出BRAF基因变异与皮肤恶性黑素瘤的关系.随着探索的深入,部分学者以BRAF基因作为治疗靶向进行研究,并初步取得成果.对BRAF基因及其突变的研究可能在未来恶性黑素瘤诊断、治疗以及预后等方面产生临床价值,为恶性黑素瘤的治疗开辟新的方向.
|
关 键 词: | 黑色素瘤 基因,BRAF 突变 |
BRAF gene mutation and cutaneous melanoma |
| |
Abstract: | ![]() BRAF gene, located in chromosome 7q34, encodes a serine/threonine protein kinase of 67-99 kilodalton which plays an important regulating role in the pathway of mitogen-activated protein kinase (MAPK). Recent studies have revealed the relationship between BRAF gene mutation and cutaneous melanoma. Some progress has been made in the research about BRAF gene-targeting therapy. To study BRAF gene and its mutation may benefit the diagnosis, treatment and prognosis evaluation of melanoma. |
| |
Keywords: | MelanomaGene BRAFMutation |
|
|